Global FSMP for Dietary Management of Preterm Infants and Low Weight Infants Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global FSMP for Dietary Management of Preterm Infants and Low Weight Infants Market Research Report 2024
Foods for special medical purposes (FSMP) are a sub-category of foods intended for particular nutritional uses (PARNUT), also called “dietetic foods.” FSMPs are intended for the dietary management of diseases in patients with impaired digestive function such as absorption, making them the most medically-oriented food category.Preterm birth (born before 37 weeks of pregnancy) and being small for gestational age, which are the reasons for low-birth-weight (LBW), are also important indirect causes of neonatal deaths. LBW contributes to 60% to 80% of all neonatal deaths. The global prevalence of LBW is 15.5%, which amounts to about 20 million LBW infants born each year, 96.5% of them in developing countries.In this report, we stud the food for special medical purposes for the dietary management of preterm infants/Low weight infants.
According to Mr Accuracy reports new survey, global FSMP for Dietary Management of Preterm Infants and Low Weight Infants market is projected to reach US$ 916.3 million in 2029, increasing from US$ 400 million in 2022, with the CAGR of 12.5% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole FSMP for Dietary Management of Preterm Infants and Low Weight Infants market research.
The FSMP (Food for Special Medical Purposes) for Dietary Management of Preterm Infants and Low Weight Infants market is primarily driven by the critical need for specialized nutrition to support the growth and development of vulnerable infants. FSMPs are formulated to provide essential nutrients for preterm and low birth weight infants who have specific dietary requirements. The increasing rates of preterm births and the emphasis on optimizing neonatal care, coupled with advancements in neonatology and nutritional science, contribute to market growth. Moreover, the demonstrated benefits of FSMPs in reducing complications and promoting healthy growth further propel adoption. However, challenges include formulating nutritionally balanced products that cater to the unique needs of premature and low weight infants and addressing potential safety concerns related to ingredient sourcing and preparation. Navigating regulatory approvals, tailoring nutrition plans to individual infants' needs, and ensuring effective communication between healthcare providers and parents are ongoing concerns. The market's success relies on continuous research in infant nutrition, collaborations between medical nutrition manufacturers and healthcare professionals, and comprehensive education on the benefits and potential risks of FSMPs for preterm and low birth weight infants while addressing the evolving challenges associated with neonatal care and nutritional support.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global FSMP for Dietary Management of Preterm Infants and Low Weight Infants market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Nestle
Danone Nutricia
Abbott
MeadJohnson
Ajinomoto
Yili Group
Feihe
Beingmate
Synutra International
Milupa Gmbh
Segment by Type
Powder
Liquid
Online
Offline
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The FSMP for Dietary Management of Preterm Infants and Low Weight Infants report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports new survey, global FSMP for Dietary Management of Preterm Infants and Low Weight Infants market is projected to reach US$ 916.3 million in 2029, increasing from US$ 400 million in 2022, with the CAGR of 12.5% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole FSMP for Dietary Management of Preterm Infants and Low Weight Infants market research.
The FSMP (Food for Special Medical Purposes) for Dietary Management of Preterm Infants and Low Weight Infants market is primarily driven by the critical need for specialized nutrition to support the growth and development of vulnerable infants. FSMPs are formulated to provide essential nutrients for preterm and low birth weight infants who have specific dietary requirements. The increasing rates of preterm births and the emphasis on optimizing neonatal care, coupled with advancements in neonatology and nutritional science, contribute to market growth. Moreover, the demonstrated benefits of FSMPs in reducing complications and promoting healthy growth further propel adoption. However, challenges include formulating nutritionally balanced products that cater to the unique needs of premature and low weight infants and addressing potential safety concerns related to ingredient sourcing and preparation. Navigating regulatory approvals, tailoring nutrition plans to individual infants' needs, and ensuring effective communication between healthcare providers and parents are ongoing concerns. The market's success relies on continuous research in infant nutrition, collaborations between medical nutrition manufacturers and healthcare professionals, and comprehensive education on the benefits and potential risks of FSMPs for preterm and low birth weight infants while addressing the evolving challenges associated with neonatal care and nutritional support.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global FSMP for Dietary Management of Preterm Infants and Low Weight Infants market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Nestle
Danone Nutricia
Abbott
MeadJohnson
Ajinomoto
Yili Group
Feihe
Beingmate
Synutra International
Milupa Gmbh
Segment by Type
Powder
Liquid
Segment by Application
Online
Offline
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The FSMP for Dietary Management of Preterm Infants and Low Weight Infants report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices